To investigate the antiviral activity of MIT-001 against SARS-CoV-2 B.1, Vero E6 and hACE2-A549 cells were inf

/MIT-001 reduces SARS-CoV-2 B.1 replication by 1000-fold at 30 µM with EC50 of 1.77 µM in Vero E6 cells